David R. Wood is the current Head of Medical Affairs at Milestone Pharmaceuticals, a bio-pharmaceutical company developing therapeutic treatments for PSVT and other arrhythmias. He holds a PhD in Biomedical Science, focused in Molecular Genetics and Cellular Biology. His career began in an academic research setting and was related to stem-cell and gene therapy for the treatment of cardiovascular and metabolic disorders. He has since established a career track-record as an entrepreneur and medical scientist leader, experienced in academic and industry research across a broad range of therapeutic areas. He has a particular passion for education and research related to diseases of under-served populations. He operates under a leadership philosophy of serving those he leads and always with the ultimate needs of the patient in mind.